Kvantify Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $52.2M

  • Investors
  • 13

Kvantify General Information

Description

Developer of a healthcare platform designed to solve computational challenges in drug discovery. The company's platform facilitates computational drug technology to improve the quality of compounds tested in the lab by leveraging proprietary, accurate physics-based methods, enabling life sciences companies to accelerate small molecule research and deliver actionable results that make a difference.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rosenvængets Allé 25 Street
  • 2100 Copenhagen
  • Denmark
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • Rosenvængets Allé 25 Street
  • 2100 Copenhagen
  • Denmark

Kvantify Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kvantify Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Early Stage VC 05-Mar-2026 $52.2M Completed Generating Revenue
7. Accelerator/Incubator Completed Generating Revenue
6. Secondary Transaction - Private Completed Generating Revenue
5. Seed Round 03-Jul-2024 Completed Generating Revenue
4. Accelerator/Incubator 16-Oct-2023 Completed Generating Revenue
3. Seed Round 14-Jun-2023 Completed Generating Revenue
2. Grant 30-Mar-2023 $1.99M Completed Generating Revenue
1. Seed Round 15-Aug-2022 $1.99M $1.99M Completed Startup
To view Kvantify’s complete valuation and funding history, request access »

Kvantify Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 13,143 $126.22 $126.22 1x $126.22 7.85%
Ordinary 12,000 $36.06 $36.06 1x $36.06 7.16%
To view Kvantify’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Kvantify Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a healthcare platform designed to solve computational challenges in drug discovery. The company's platform
Discovery Tools (Healthcare)
Copenhagen, Denmark
60 As of 2026

Paris, France
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kvantify Competitors (18)

One of Kvantify’s 18 competitors is Ariana Pharma, a Formerly VC-backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ariana Pharma Formerly VC-backed Paris, France
Liberum Biotech Venture Capital-Backed San Francisco, CA
POLARISqb Venture Capital-Backed Durham, NC
ProteinQure Venture Capital-Backed Toronto, Canada
Manifold Bio Venture Capital-Backed Boston, MA
You’re viewing 5 of 18 competitors. Get the full list »

Kvantify Patents

Kvantify Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026201921-A1 Methods and systems for quantum simulation Pending 24-Mar-2025
EP-4673950-A1 System and method for modelling molecular interactions Pending 01-Mar-2023
WO-2024180257-A1 System and method for modelling molecular interactions Inactive 01-Mar-2023 G16C10/00

Kvantify Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kvantify Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Delphinus Venture Capital Venture Capital Minority
Nordic Makers Venture Capital Minority
Dreamcraft Ventures Venture Capital Minority
Lundbeckfonden BioCapital Venture Capital Minority
QAI Ventures Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Kvantify FAQs

  • When was Kvantify founded?

    Kvantify was founded in 2022.

  • Where is Kvantify headquartered?

    Kvantify is headquartered in Copenhagen, Denmark.

  • What is the size of Kvantify?

    Kvantify has 60 total employees.

  • What industry is Kvantify in?

    Kvantify’s primary industry is Discovery Tools (Healthcare).

  • Is Kvantify a private or public company?

    Kvantify is a Private company.

  • What is Kvantify’s current revenue?

    The current revenue for Kvantify is .

  • How much funding has Kvantify raised over time?

    Kvantify has raised $70.4M.

  • Who are Kvantify’s investors?

    Delphinus Venture Capital, Nordic Makers, Dreamcraft Ventures, Lundbeckfonden BioCapital, and QAI Ventures are 5 of 13 investors who have invested in Kvantify.

  • Who are Kvantify’s competitors?

    Ariana Pharma, Liberum Biotech, POLARISqb, ProteinQure, and Manifold Bio are some of the 18 competitors of Kvantify.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process